Clinical Trial Update: Use of NAVA in Intubated Preterm [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates that the NAVA study in intubated preterm infants (NCT00536445) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome of Newborn

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Infant, Premature, Respiration, Artificial | Phase 1, Phase 2 | Status: WITHDRAWN